Sarcoidosis and multiple sclerosis: Systemic toxicity associated with the use of interferon-beta therapy

Cristiano Carbonelli, S. Montepietra, A. Caruso, A. Cavazza, C. Feo, F. Menzella, L. Motti, L. Zucchi

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Sarcoidosis is a multi-systemic inflammatory disease of unknown origin characterized by the presence of noncaseating epitheloid cell granulomas in multiple organs. Diagnosis is made on the basis of a compatible clinical-radiological scenario and the histological demonstration of the typical granulomas in the affected tissues. Interferons are immuno-modulators that have been used in a wide range of diseases, including hepatitis C virus infection, multiple sclerosis, and multiple myeloma and other types of tumours, including leukemia, lymphomas, Kaposi's sarcoma, and melanoma. Interferon-α-induced sarcoidosis has been reported repeatedly and there are two reports in the literature of cases of pulmonary sarcoidosis treated with interferon-1b therapy: one for advanced renal cell carcinoma and the other for multiple myeloma. A 35-year-old man on chronic immune-modulant Interferon-1b-based therapy for multiple sclerosis presented to the Neurology Unit with mild dyspnoea, dry cough, and transient pain to right upper abdomen. Lungs, spleen, liver, and almost all lymphnode stations of abdomen and mediastinum were clearly involved on ultrasound examination, chest X-ray, and computed tomography. A transbronchial biopsy showed non-caseating granuloma on histopathologic evaluation of the lungs. To the best of our knowledge, this is the first report of a chronic multisystemic sarcoidosis that was associated with interferon-beta treatment.

Original languageEnglish
Pages (from-to)29-31
Number of pages3
JournalMonaldi Archives for Chest Disease - Cardiac Series
Volume77
Issue number1
Publication statusPublished - Mar 2012

Fingerprint

Interferon-beta
Sarcoidosis
Granuloma
Interferons
Multiple Sclerosis
Multiple Myeloma
Abdomen
Pulmonary Sarcoidosis
Lung
X Ray Computed Tomography
Kaposi's Sarcoma
Mediastinum
Virus Diseases
Neurology
Renal Cell Carcinoma
Cough
Hepacivirus
Dyspnea
Interferon-gamma
Melanoma

Keywords

  • Adverse effects
  • Demyelinating diseases
  • Interferons
  • Management
  • Medication
  • Multiple sclerosis
  • Neurological disorders
  • Sarcoidosis

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Sarcoidosis and multiple sclerosis : Systemic toxicity associated with the use of interferon-beta therapy. / Carbonelli, Cristiano; Montepietra, S.; Caruso, A.; Cavazza, A.; Feo, C.; Menzella, F.; Motti, L.; Zucchi, L.

In: Monaldi Archives for Chest Disease - Cardiac Series, Vol. 77, No. 1, 03.2012, p. 29-31.

Research output: Contribution to journalArticle

Carbonelli, C, Montepietra, S, Caruso, A, Cavazza, A, Feo, C, Menzella, F, Motti, L & Zucchi, L 2012, 'Sarcoidosis and multiple sclerosis: Systemic toxicity associated with the use of interferon-beta therapy', Monaldi Archives for Chest Disease - Cardiac Series, vol. 77, no. 1, pp. 29-31.
Carbonelli, Cristiano ; Montepietra, S. ; Caruso, A. ; Cavazza, A. ; Feo, C. ; Menzella, F. ; Motti, L. ; Zucchi, L. / Sarcoidosis and multiple sclerosis : Systemic toxicity associated with the use of interferon-beta therapy. In: Monaldi Archives for Chest Disease - Cardiac Series. 2012 ; Vol. 77, No. 1. pp. 29-31.
@article{6baf361b0b884804b1e307607811411f,
title = "Sarcoidosis and multiple sclerosis: Systemic toxicity associated with the use of interferon-beta therapy",
abstract = "Sarcoidosis is a multi-systemic inflammatory disease of unknown origin characterized by the presence of noncaseating epitheloid cell granulomas in multiple organs. Diagnosis is made on the basis of a compatible clinical-radiological scenario and the histological demonstration of the typical granulomas in the affected tissues. Interferons are immuno-modulators that have been used in a wide range of diseases, including hepatitis C virus infection, multiple sclerosis, and multiple myeloma and other types of tumours, including leukemia, lymphomas, Kaposi's sarcoma, and melanoma. Interferon-α-induced sarcoidosis has been reported repeatedly and there are two reports in the literature of cases of pulmonary sarcoidosis treated with interferon-1b therapy: one for advanced renal cell carcinoma and the other for multiple myeloma. A 35-year-old man on chronic immune-modulant Interferon-1b-based therapy for multiple sclerosis presented to the Neurology Unit with mild dyspnoea, dry cough, and transient pain to right upper abdomen. Lungs, spleen, liver, and almost all lymphnode stations of abdomen and mediastinum were clearly involved on ultrasound examination, chest X-ray, and computed tomography. A transbronchial biopsy showed non-caseating granuloma on histopathologic evaluation of the lungs. To the best of our knowledge, this is the first report of a chronic multisystemic sarcoidosis that was associated with interferon-beta treatment.",
keywords = "Adverse effects, Demyelinating diseases, Interferons, Management, Medication, Multiple sclerosis, Neurological disorders, Sarcoidosis",
author = "Cristiano Carbonelli and S. Montepietra and A. Caruso and A. Cavazza and C. Feo and F. Menzella and L. Motti and L. Zucchi",
year = "2012",
month = "3",
language = "English",
volume = "77",
pages = "29--31",
journal = "Monaldi Archives for Chest Disease",
issn = "1122-0643",
publisher = "Fondazione Salvatore Maugeri",
number = "1",

}

TY - JOUR

T1 - Sarcoidosis and multiple sclerosis

T2 - Systemic toxicity associated with the use of interferon-beta therapy

AU - Carbonelli, Cristiano

AU - Montepietra, S.

AU - Caruso, A.

AU - Cavazza, A.

AU - Feo, C.

AU - Menzella, F.

AU - Motti, L.

AU - Zucchi, L.

PY - 2012/3

Y1 - 2012/3

N2 - Sarcoidosis is a multi-systemic inflammatory disease of unknown origin characterized by the presence of noncaseating epitheloid cell granulomas in multiple organs. Diagnosis is made on the basis of a compatible clinical-radiological scenario and the histological demonstration of the typical granulomas in the affected tissues. Interferons are immuno-modulators that have been used in a wide range of diseases, including hepatitis C virus infection, multiple sclerosis, and multiple myeloma and other types of tumours, including leukemia, lymphomas, Kaposi's sarcoma, and melanoma. Interferon-α-induced sarcoidosis has been reported repeatedly and there are two reports in the literature of cases of pulmonary sarcoidosis treated with interferon-1b therapy: one for advanced renal cell carcinoma and the other for multiple myeloma. A 35-year-old man on chronic immune-modulant Interferon-1b-based therapy for multiple sclerosis presented to the Neurology Unit with mild dyspnoea, dry cough, and transient pain to right upper abdomen. Lungs, spleen, liver, and almost all lymphnode stations of abdomen and mediastinum were clearly involved on ultrasound examination, chest X-ray, and computed tomography. A transbronchial biopsy showed non-caseating granuloma on histopathologic evaluation of the lungs. To the best of our knowledge, this is the first report of a chronic multisystemic sarcoidosis that was associated with interferon-beta treatment.

AB - Sarcoidosis is a multi-systemic inflammatory disease of unknown origin characterized by the presence of noncaseating epitheloid cell granulomas in multiple organs. Diagnosis is made on the basis of a compatible clinical-radiological scenario and the histological demonstration of the typical granulomas in the affected tissues. Interferons are immuno-modulators that have been used in a wide range of diseases, including hepatitis C virus infection, multiple sclerosis, and multiple myeloma and other types of tumours, including leukemia, lymphomas, Kaposi's sarcoma, and melanoma. Interferon-α-induced sarcoidosis has been reported repeatedly and there are two reports in the literature of cases of pulmonary sarcoidosis treated with interferon-1b therapy: one for advanced renal cell carcinoma and the other for multiple myeloma. A 35-year-old man on chronic immune-modulant Interferon-1b-based therapy for multiple sclerosis presented to the Neurology Unit with mild dyspnoea, dry cough, and transient pain to right upper abdomen. Lungs, spleen, liver, and almost all lymphnode stations of abdomen and mediastinum were clearly involved on ultrasound examination, chest X-ray, and computed tomography. A transbronchial biopsy showed non-caseating granuloma on histopathologic evaluation of the lungs. To the best of our knowledge, this is the first report of a chronic multisystemic sarcoidosis that was associated with interferon-beta treatment.

KW - Adverse effects

KW - Demyelinating diseases

KW - Interferons

KW - Management

KW - Medication

KW - Multiple sclerosis

KW - Neurological disorders

KW - Sarcoidosis

UR - http://www.scopus.com/inward/record.url?scp=84861156363&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84861156363&partnerID=8YFLogxK

M3 - Article

C2 - 22662644

AN - SCOPUS:84861156363

VL - 77

SP - 29

EP - 31

JO - Monaldi Archives for Chest Disease

JF - Monaldi Archives for Chest Disease

SN - 1122-0643

IS - 1

ER -